SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001555192-21-000002
Filing Date
2021-11-12
Accepted
2021-11-12 15:54:12
Documents
1
Effectiveness Date
2021-11-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13140
  Complete submission text file 0001555192-21-000002.txt   14433
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, SUITE 14303 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, SUITE 14303 CAMBRIDGE MA 02139 857-209-0056
Elicio Therapeutics, Inc. (Filer) CIK: 0001555192 (see all company filings)

IRS No.: 452966790 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-417559 | Film No.: 211403123
SIC: 2834 Pharmaceutical Preparations